NSCLC patients respond best to salvage chemo if pre-treated with checkpoint inhibitors
Geneva, Switzerland, 04 May 2017 - Patients with advanced non-small-cell lung cancer (NSCLC) who require salvage chemotherapy are 30% more likely to achieve a partial...







